TheProfitWatch

VYNE - VYNE Therapeutics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.39 -0.01 (-1.28%) 0.0 (0.0%) 0.0 (0.0%) 0.0 (1.29%) 0.01 (2.59%) -0.01 (-2.67%) 0.0 (0.03%) 0.0 (0.03%)

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.13
Diluted EPS:
-0.13
Basic P/E:
-2.9615
Diluted P/E:
-2.9615
RSI(14) 1m:
100.0
VWAP:
0.39
RVol:

Events

Period Kind Movement Occurred At

Related News